ABBVVSREGN• 28 Days (Normalized)
ABBV vs REGN (AbbVie Inc. vs Regeneron Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABBV Performance $271.36
+6.42%
AbbVie Inc.
Normalized Baseline0.00%
REGN Performance $742.12
-6.45%
Regeneron Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABBV LEADS
+12.87 pts
ABBV outperforming by 12.87 percentage points
ABBVREGN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABBV REGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ABBV Price | ABBV Gain (%) | REGN Price | REGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $271.36 | +6.42% | $742.12 | -6.45% | +12.87% |
| Oct 06, 2026 | $266.69 | +4.58% | $738.72 | -6.88% | +11.46% |
| Oct 05, 2026 | $265.76 | +4.22% | $726.47 | -8.42% | +12.64% |
| Oct 02, 2026 | $262.82 | +3.07% | $735.20 | -7.32% | +10.39% |
| Oct 01, 2026 | $259.93 | +1.93% | $- | - | |
| Sep 30, 2026 | $261.59 | +2.58% | $758.27 | -4.41% | +6.99% |
| Sep 29, 2026 | $263.29 | +3.25% | $750.51 | -5.39% | +8.64% |
| Sep 28, 2026 | $266.28 | +4.42% | $752.25 | -5.17% | +9.59% |
| Sep 25, 2026 | $264.34 | +3.66% | $788.04 | -0.66% | +4.32% |
| Sep 24, 2026 | $- | $796.02 | +0.35% | - | |
| Sep 23, 2026 | $265.08 | +3.95% | $801.82 | +1.08% | +2.87% |
| Sep 22, 2026 | $265.21 | +4.00% | $803.90 | +1.34% | +2.66% |
| Sep 21, 2026 | $264.48 | +3.72% | $798.17 | +0.62% | +3.10% |
| Sep 18, 2026 | $263.96 | +3.51% | $784.85 | -1.06% | +4.57% |
| Sep 17, 2026 | $264.02 | +3.54% | $789.45 | -0.48% | +4.02% |
Page 1 of 2